Open | - |
Close | - |
Volume / Avg. | 0 / 588.343K |
Day Range | - - - |
52 Wk Range | 29.675 - 59.610 |
Market Cap | $1.520B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 5.06% |
Days to Cover | 4.07 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AtriCure (NASDAQ: ATRC) through any online brokerage.
Other companies in AtriCure’s space includes: SI-BONE (NASDAQ:SIBN), Varex Imaging (NASDAQ:VREX), Envista Holdings (NYSE:NVST), Inari Medical (NASDAQ:NARI) and Alphatec Holdings (NASDAQ:ATEC).
The latest price target for AtriCure (NASDAQ: ATRC) was reported by UBS on Friday, February 16, 2024. The analyst firm set a price target for 58.00 expecting ATRC to rise to within 12 months (a possible 81.59% upside). 14 analyst firms have reported ratings in the last year.
The stock price for AtriCure (NASDAQ: ATRC) is $31.94 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for AtriCure.
AtriCure’s Q1 earnings are confirmed for Tuesday, April 30, 2024.
There is no upcoming split for AtriCure.
AtriCure is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.